Assessment of gender sensitivity of the drug harm reduction program for youth in Serbia

This gender analysis of harm reduction services for young people who use drugs (PWUD) “Assessment of gender sensitivity of the drug harm reduction program for youth in Serbia“, published by our member organisation Prevent from Novi Sad, was conducted within the Erasmus+ regional project “Creating Gender-Based Programs for Young People Who Use Drugs,” with the aim of identifying gender-related barriers, gaps, and opportunities in existing programs. The study places a strong focus on the needs and lived experiences of young PWUD, including those of diverse gender identities and sexual orientations, while assessing the level of gender sensitivity and inclusiveness of current services. In 2025, the harm reduction landscape in Serbia is marked by the absence of an updated national strategy, weakening multisectoral cooperation, and the exclusion of civil society organizations (CSOs) from policymaking processes. Existing policies only partially recognize harm reduction and lack gender-specific or transformative approaches, while the legal framework remains repressive and discourages service access. Additionally, there is a significant lack of gender-disaggregated data and gender analysis in public systems, alongside documented discrimination against women, trans, and LGBTQAI+ individuals. Despite these challenges, CSOs continue to play a crucial role as primary service providers, offering essential support such as sterile equipment, testing, counselling, and safe spaces, though they face limited funding, administrative barriers, and declining international support, putting especially gender-sensitive and youth-focused services at risk of closure.

The findings highlight that women – particularly sex workers, Roma women, and trans and non-binary individuals – face multiple and intersecting forms of marginalization, compounded by the lack of gender-responsive services and systemic exclusion from public institutions. There is a clear need for more inclusive, gender-sensitive, and accessible approaches, including mobile and night outreach, integrated legal and healthcare support, and safe shelters. While CSOs are actively developing anti-stigma protocols, gender-neutral spaces, staff training, and protection mechanisms, their efforts remain constrained by unstable funding. Accordingly, the recommendations emphasize the urgent need to integrate a gender perspective into public policies, ensure sustainable institutional funding for CSOs, reform punitive legal frameworks, and enable meaningful participation of both CSOs and young PWUD in decision-making. At the organizational and programmatic levels, priorities include diversifying funding sources, strengthening partnerships, preserving core services, expanding peer-led and gender-sensitive programs, improving outreach and communication, addressing violence, and investing in continuous monitoring and staff capacity building. Overall, a coordinated and gender-responsive systemic shift is essential to ensure equitable, sustainable, and effective harm reduction services in Serbia.

The report, in Serbian, is available following this link>>>.

Prevent also published a comparative report which is the result of collaboration between civil society organizations from three countries: Prevent from Novi Sad, HOPS from Skopje, and Sananim from Prague. It provides a comprehensive overview and comparison of three national gender analyses of harm reduction programs conducted in Serbia, North Macedonia, and the Czech Republic during 2025, using a shared methodology. The main objective was to identify gender-related barriers, gaps, and opportunities within existing harm reduction services, with a particular focus on the needs and experiences of young people who use drugs, including individuals of diverse gender identities and sexual orientations. The report examines the extent to which services are gender-sensitive, inclusive, and responsive to the specific needs of users, taking into account the influence of gender norms, identities, and structural inequalities on both access to and quality of services.

The analysis combines two key components: a desk review of existing strategies and policy frameworks, and qualitative insights gathered through semi-structured interviews with organizations working directly with marginalized communities, including people who use drugs, sex workers, LGBTI+ individuals, and youth. To ensure a standardized and evidence-based assessment, the evaluation of programs and policies was conducted using the World Health Organization’s Gender Responsive Assessment Scale (GRAS), which enabled the identification of levels of gender responsiveness as well as critical gaps across the three national contexts. This comparative approach not only highlights shared challenges but also provides a foundation for developing more inclusive, gender-responsive harm reduction policies and practices across the region.

The report is available in Serbian following this link>>>.

Updates on the 5th European Harm Reduction Conference

After being postponed from 2020 to this year due to coronavirus pandemic, the Correlation – European Harm Reduction Network (C-EHRN) are proud to finally re-announce the 5th European Harm Reduction Conference. Together with Czech organisation Sananim, Eurasian Harm Reduction Association, the European Network of People Who Use Drugs, the World Health Organization Regional Office for Europe, the European Monitoring Centre for Drugs and Drug Addiction and other important stakeholders from Europe they are currently constructing its exciting programme.

The conference will present the latest harm reduction developments and good, innovative practices. It will discuss drug policy and its implications on People Who Use Drugs and other marginalised groups, such as sex workers and People Living with HIV/Aids. It intends to discuss different perspectives on harm reduction, social inclusion and related topics. Finally, the conference provides an appropriate platform to create links and synergies between national and European stakeholders.

The 5th European Harm Reduction Conference targets professionals from the community, professionals working in the broader area of harm reduction, policy-makers and politicians, advocacy representatives, researchers, and media representatives.

With the out role of test and vaccination strategies in Europe, you are invited to a most probable face-to-face meeting in November. Join us and unmute yourself in the safe and pleasant environment we thrive to guarantee with all necessary measures.

In case of unforeseen developments and a worst-case scenario that might urge a re-cancellation, registration fees will be refunded, and sessions will be transferred to an online format.

Key dates:

  • Registration open: May 2021
  • Abstract submission: 1 May – 1 July
  • Abstract confirmation deadline: 15 September
  • Early Bird rate deadline: 30 September

To read more and register follow this link>>>.

 

Czech drug policy model preserved

A week ago, we posted a news with an urgent call to support the Open letter to the Prime Minister of the Czech Republic to preserve its successful drug policy model, as our colleagues from the Czech Republic informed the international community that the Prime Minister is intending to move the Secretariat of the Council for Drug Coordination and its monitoring centre from the Office of the Government to the Ministry of Health.

DPNSEE was among 407 signatures to support the Open letter. And it worked!!!

As a result of expert pressure, the Czech government decided to desist from the intended move which we all feared would threaten the interdisciplinary model of Czech drug policy and endanger the funding of harm reduction and social services.

The support from international as well as domestic experts and professionals has been overwhelming and, apparently, has (once again) helped to preserve the Czech drug policy model.

For more details, please see a press release of the Czech government announcing that they desist from the move. The English translation is below:

THE OFFICE OF GOVERNMENT DESISTS FROM MOVING THE DRUG AGENDA UNDER THE MINISTRY OF HEALTH
4. 7. 2019 16:43

Regarding the fact that according to the Competence Act, the Office of Government should perform tasks related to the expert, organisational and technical aspects of the work done by the Government of the Czech Republic and its bodies, it has been considered that as a part of making the Office of Government more effective, the Secretariat of the Government Council for Drug Policy Coordination would be moved under the Ministry of Health with the prime minister continuing to preside the Council.

This wasn’t an isolated step. During the last year, the Governmental Council for Coordination of the Fight Against Corruption was moved under the Ministry of Justice and the agenda of social inclusion will move under the Ministry of Regional Development. In line with this, moving the drug agenda was being considered.

Due to the expert opinion that the move could diminish the importance of the drug agenda and that the discussion about moving was still undergoing, the Office of Government has decided to desist from this step. Secretariat of the Government Council for Drug Policy Coordination, currently lead by the National Drug Coordinator, will stay under the Office of Government.

Join an open letter to the Czech Prime Minister to preserve its drug policy

Our colleagues from the Czech Republic informed the international community that the Prime Minister is intending to move the Secretariat of the Council for Drug Coordination and its monitoring centre from the Office of the Government to the Ministry of Health.

As explained in the Open letter to the Prime Minister of the Czech Republic to preserve its successful drug policy model, this would have a negative effect on the interdisciplinary nature of drug policy in the Czech Republic and lead to restricted funding for social and harm reduction programmes in the future.

We have had a good communication with the Czech Secretariat and its National Monitoring Centre and learned a lot from their successful drug policy model. For this reason, DPNSEE supported the petition.

If you want to read and supported the petition follow this link>>>

DPNSEE participation on Rational Drug Regulations Conference

From 4 to 6 October in Brno, Czech Republic, the Conference on Rational Drug Regulation was held, organised by A.N.O. – Asociace nestatnichne ziskovych organizaci a Spolecnost Podaneruce o.p.s

The conference had an aim to start the dialogue and question social, political and professional attitudes that are going through phase of change that we can witness. At the states level we see examples of changing policies regarding cannabis for example, but on the other hand we still see policymakers practice the so call war on drugs. Rationality of Drug Regulations Conference aimed to open space for the dialogue regarding how these trends are reflecting on the local level? How are the local governments, relevant activist groups or organisations, activist groups, police forces, schools dealing with this changing situations? The Conference aimed primarily at professionals; however, it was also open to members of public interested in the topics.

Within the panel “Harm reduction: Between professionalization and activism”, DPNSEE Staff member Irena Molnar was representing the cases of SEE, and from this point of view she was presenting case study “Serbia’s Drug Policy Crossroad – Will EU accession period bring more balanced approach to (recreational) drug use?“

The conference also discussed topics on: How are these trends reflected at the local level? How are they advocated, explained and interpreted by the general public? What direct experience do the specific villages, towns, neighbourhoods, and streets have with these? How are the local governments, relevant organizations, activist groups, police forces, schools or helping network services dealing with the changing situation of the drug regulation?

More about conference program and keynote speakers you can find on the conference website. Also, check the book of abstracts